| Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes ADVANCE Collaborative Group New England journal of medicine 358 (24), 2560-2572, 2008 | 10291 | 2008 |
| Canagliflozin and renal outcomes in type 2 diabetes and nephropathy V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, ... New England journal of medicine 380 (24), 2295-2306, 2019 | 5628 | 2019 |
| A randomized, controlled trial of early versus late initiation of dialysis BA Cooper, P Branley, L Bulfone, JF Collins, JC Craig, MB Fraenkel, ... New England Journal of Medicine 363 (7), 609-619, 2010 | 1051 | 2010 |
| Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy A Levin, M Tonelli, J Bonventre, J Coresh, JA Donner, AB Fogo, CS Fox, ... The Lancet 390 (10105), 1888-1917, 2017 | 1000 | 2017 |
| Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ... The Lancet 393 (10184), 1937-1947, 2019 | 546 | 2019 |
| Glucose handling by the kidney A Mather, C Pollock Kidney international 79, S1-S6, 2011 | 459 | 2011 |
| The influence of dialysis treatment modality on the decline of remaining renal function MJ Lysaght, EF Vonesh, F Gotch, L Ibels, M Keen, B Lindholm, KD Nolph, ... Asaio Journal 37 (4), 598-604, 1991 | 437 | 1991 |
| Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease Sharp Collaborative Group American heart journal 160 (5), 785-794. e10, 2010 | 427 | 2010 |
| Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference CT Chan, PJ Blankestijn, LM Dember, M Gallieni, DCH Harris, CE Lok, ... Kidney international 96 (1), 37-47, 2019 | 382 | 2019 |
| Effects of SGLT2 inhibition in human kidney proximal tubular cells—renoprotection in diabetic nephropathy? U Panchapakesan, K Pegg, S Gross, MG Komala, H Mudaliar, J Forbes, ... PloS one 8 (2), e54442, 2013 | 350 | 2013 |
| Developing a set of core outcomes for trials in hemodialysis: an international Delphi survey N Evangelidis, A Tong, B Manns, B Hemmelgarn, DC Wheeler, P Tugwell, ... American Journal of Kidney Diseases 70 (4), 464-475, 2017 | 302 | 2017 |
| Canagliflozin and cardiovascular and renal outcomes in type 2 diabetes mellitus and chronic kidney disease in primary and secondary cardiovascular prevention groups: results … KW Mahaffey, MJ Jardine, S Bompoint, CP Cannon, B Neal, ... Circulation 140 (9), 739-750, 2019 | 291 | 2019 |
| Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis ISPD Adequacy of Peritoneal Dialysis Working Group Peritoneal dialysis international 26 (5), 520-522, 2006 | 276 | 2006 |
| Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference IC Macdougall, AJ Bircher, KU Eckardt, GT Obrador, CA Pollock, ... Kidney international 89 (1), 28-39, 2016 | 266 | 2016 |
| The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) study rationale, design, and baseline characteristics MJ Jardine, KW Mahaffey, B Neal, R Agarwal, GL Bakris, BM Brenner, ... American journal of nephrology 46 (6), 462-472, 2018 | 258 | 2018 |
| Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD BA Cooper, EL Penne, LH Bartlett, CA Pollock American Journal of Kidney Diseases 43 (1), 61-66, 2004 | 252 | 2004 |
| Validity of subjective global assessment as a nutritional marker in end-stage renal disease BA Cooper, LH Bartlett, A Aslani, BJ Allen, LS Ibels, CA Pollock American journal of kidney diseases 40 (1), 126-132, 2002 | 227 | 2002 |
| Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial GS Doig, F Simpson, R Bellomo, PT Heighes, EA Sweetman, D Chesher, ... Intensive care medicine 41, 1197-1208, 2015 | 219 | 2015 |
| Establishing core outcome domains in hemodialysis: report of the Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) consensus workshop A Tong, B Manns, B Hemmelgarn, DC Wheeler, N Evangelidis, P Tugwell, ... American Journal of Kidney Diseases 69 (1), 97-107, 2017 | 213 | 2017 |
| Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference JE Flythe, TI Chang, MP Gallagher, E Lindley, M Madero, PA Sarafidis, ... Kidney international 97 (5), 861-876, 2020 | 210 | 2020 |
